These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 2682131)
1. Adverse reactions and interactions of the neuromuscular blocking drugs. Ostergaard D; Engbaek J; Viby-Mogensen J Med Toxicol Adverse Drug Exp; 1989; 4(5):351-68. PubMed ID: 2682131 [TBL] [Abstract][Full Text] [Related]
2. Interactions of neuromuscular blocking drugs. Cammu G Acta Anaesthesiol Belg; 2001; 52(4):357-63. PubMed ID: 11799568 [TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacology of neuromuscular blocking agents. Fisher DM Am J Health Syst Pharm; 1999 Jun; 56(11 Suppl 1):S4-9. PubMed ID: 10437710 [TBL] [Abstract][Full Text] [Related]
4. Adverse effects of neuromuscular blockers and their antagonists. Naguib M; Magboul MM Middle East J Anaesthesiol; 1998 Jun; 14(5):341-73. PubMed ID: 9785339 [TBL] [Abstract][Full Text] [Related]
5. Clinical pharmacokinetics of neuromuscular relaxants in pregnancy. Guay J; Grenier Y; Varin F Clin Pharmacokinet; 1998 Jun; 34(6):483. PubMed ID: 9646009 [TBL] [Abstract][Full Text] [Related]
6. Neuromuscular transmission and its pharmacological blockade. Part 2: Pharmacology of neuromuscular blocking agents. Booij LH Pharm World Sci; 1997 Feb; 19(1):13-34. PubMed ID: 9089750 [TBL] [Abstract][Full Text] [Related]
7. Adverse effects of neuromuscular blockers and their antagonists. Naguib M; Magboul MM Drug Saf; 1998 Feb; 18(2):99-116. PubMed ID: 9512917 [TBL] [Abstract][Full Text] [Related]
8. A comparison of the neuromuscular blocking and autonomic effects of two new short-acting muscle relaxants with those of succinylcholine in the anesthetized cat and pig. Muir AW; Houston J; Marshall RJ; Bowman WC; Marshall IG Anesthesiology; 1989 Mar; 70(3):533-40. PubMed ID: 2564263 [TBL] [Abstract][Full Text] [Related]
9. [Profile of the effect of succinylcholine after pre-curarization with atracurium, vecuronium or pancuronium]. Ebeling BJ; Keienburg T; Hausmann D; Apffelstaedt C Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Jun; 31(5):304-8. PubMed ID: 8767244 [TBL] [Abstract][Full Text] [Related]
10. Adverse effects of depolarising neuromuscular blocking agents. Incidence, prevention and management. Book WJ; Abel M; Eisenkraft JB Drug Saf; 1994 May; 10(5):331-49. PubMed ID: 8037887 [TBL] [Abstract][Full Text] [Related]
11. Mutual potentiation of the neuromuscular effects of antibiotics and relaxants. Burkett L; Bikhazi GB; Thomas KC; Rosenthal DA; Wirta MG; Foldes FF Anesth Analg; 1979; 58(2):107-15. PubMed ID: 571233 [TBL] [Abstract][Full Text] [Related]
13. Effect of neuromuscular blocking drugs on arterial pressure and heart rate in rats. Ertama PM; Paakkari I; Paakkari P; Karppanen H Med Biol; 1984; 62(4):231-8. PubMed ID: 6151034 [TBL] [Abstract][Full Text] [Related]
14. Accelerated onset of non-depolarizing neuromuscular blocking drugs: pancuronium, atracurium and vecuronium. A comparison with succinylcholine. Mehta MP; Sokoll MD; Gergis SD Eur J Anaesthesiol; 1988 Jan; 5(1):15-21. PubMed ID: 2897912 [TBL] [Abstract][Full Text] [Related]
15. Cross-reactivity of metocurine, atracurium, vecuronium and fazadinium with IgE antibodies from patients unexposed to these drugs but allergic to other myoneural blocking drugs. Harle DG; Baldo BA; Fisher MM Br J Anaesth; 1985 Nov; 57(11):1073-6. PubMed ID: 2864946 [TBL] [Abstract][Full Text] [Related]
16. Nitroglycerin and the neuromuscular blockade produced by gallamine, succinylcholine, d-tubocurarine, and pancuronium. Glisson SN; Sanchez MM; El-Etr AA; Lim RA Anesth Analg; 1980 Feb; 59(2):117-22. PubMed ID: 6768318 [TBL] [Abstract][Full Text] [Related]
17. Acute and chronic changes in intra- and extracellular potassium and responses to neuromuscular blocking agents. Hill GE; Wong KC; Shaw CL; Blatnick RA Anesth Analg; 1978; 57(4):417-21. PubMed ID: 568402 [TBL] [Abstract][Full Text] [Related]
18. Pharmacology and use of muscle relaxants in infants and children. Nugent SK; Laravuso R; Rogers MC J Pediatr; 1979 Mar; 94(3):481-7. PubMed ID: 423041 [TBL] [Abstract][Full Text] [Related]
19. Pretreatment with d-tubocurarine, vecuronium, and pancuronium attenuates succinylcholine-induced increases in plasma norepinephrine concentrations in humans. Oshita S; Denda S; Fujiwara Y; Takeshita H; Kosaka F Anesth Analg; 1991 Jan; 72(1):84-8. PubMed ID: 1670598 [TBL] [Abstract][Full Text] [Related]